Steven Resnick in Annapolis, Maryland

Home Maryland Annapolis

Steven Resnick has Pulmonary Disease as his primary medical specialty. Their primary office is: 116 Defense Hwy in Annapolis, Maryland.

They're a part of the: Annapolis Asthma Pulmonary And Sleep Spec medical group which has around 2 members. You can call their office at 410-1644 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Maryland School Of Medicine and graduated in 1986 (around 38 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Steven Craig Resnick Office Phone and Directions

Steven Resnick
Annapolis Asthma Pulmonary And Sleep Spec
116 Defense Hwy
Annapolis, Maryland 21401
410-1644

Patient Ratings
Please rate your experience with Steven Resnick below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 410-1644

Enter a starting address:

Healthcare Info for Steven Resnick

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS)

Medical School: University Of Maryland School Of Medicine
Graduation Year: 1986
The Primary Medical Specialty for Steven Resnick is listed as: Pulmonary Disease
Approximate Years of Experience: 38
PAC (PECOS ID)#: 6608938311
NPI #: 1477555134
NPI Created On: 08/12/2005
NPI Last Updated Listed as: 06/03/2011
Primary Taxonomy Code: 207RC0200X
License Number:
D0035494
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

CareFirst BlueChoice, Inc.
Humana
Group Hospitalization and Medical Services Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Irrigation and suction of lung airways to obtain cells using an endoscope
Measurement and graphic recording of total and timed exhaled air capacity
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Diagnostic testing in a pulmonary function lab
Test for exercise-induced lung stress
Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device
Determination of lung volumes using gas dilution or washout
Measurement of lung diffusing capacity
Study of sleep patterns
Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $30

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788294509

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $39

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788294511

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $39

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788294513

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801618139

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801618401

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801618637

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: ANORO ELLIPTA

Open Associated Drug #1: 0173-0869-06

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801620747

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801623223

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801945963

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802185047

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Pulmonary Disease Professionals in Annapolis

1.
Adrien Mazer

2001 Medical Pkwy
Annapolis, MD
Luminis Health Medical Group, Llc

Providers in Annapolis Asthma Pulmonary And Sleep Spec

1.Steven Resnick

116 Defense Hwy
Annapolis Md 21401-7063
Annapolis Asthma Pulmonary And Sleep Spec
Pulmonary Disease

2.Ira Weinstein

116 Defense Hwy
Annapolis Md 21401-7063
Annapolis Asthma Pulmonary And Sleep Spec
Critical Care (intensivists)

View all 2 members of Annapolis Asthma Pulmonary And Sleep Spec medical group